Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +0.71% | -4.70% | -27.92% |
May. 13 | Transcript : Iterum Therapeutics plc, Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Iterum Therapeutics plc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 12.13M | Capitalization | 23.51M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -18M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
-0.85
x | P/E ratio 2025 * |
-1.4
x | Employees | 14 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.55% |
Latest transcript on Iterum Therapeutics plc
1 day | +0.71% | ||
1 week | -4.70% | ||
Current month | -7.19% | ||
1 month | -10.13% | ||
3 months | +5.19% | ||
6 months | -31.40% | ||
Current year | -27.92% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Dunne
FOU | Founder | 64 | 15-10-31 |
Corey Fishman
FOU | Founder | 59 | 15-06-23 |
Judith Matthews
DFI | Director of Finance/CFO | 54 | 15-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ron Hunt
CHM | Chairman | 59 | 15-10-31 |
Beth Hecht
BRD | Director/Board Member | 60 | 21-03-11 |
Corey Fishman
FOU | Founder | 59 | 15-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 1.42 | +0.71% | 57,893 |
24-05-21 | 1.41 | -2.76% | 46,158 |
24-05-20 | 1.45 | +2.84% | 124,427 |
24-05-17 | 1.41 | -4.73% | 177,590 |
24-05-16 | 1.48 | -0.67% | 63,473 |
Delayed Quote Nasdaq, May 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.92% | 23.51M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.38% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- ITRM Stock